Prosperity Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,912
Closed -$330K 160
2024
Q2
$330K Buy
2,912
+348
+14% +$44K 0.21% 96
2024
Q1
$356K Buy
2,564
+23
+0.9% +$2.89K 0.22% 96
2023
Q4
$315K Buy
2,541
+63
+3% +$6.44K 0.22% 91
2023
Q3
$231K Buy
2,478
+143
+6% +$16.1K 0.19% 96
2023
Q2
$300K Buy
2,335
+145
+7% +$17.5K 0.26% 87
2023
Q1
$254K Buy
2,190
+33
+2% +$3.69K 0.26% 79
2022
Q4
$244K Buy
+2,157
New +$237K 0.26% 75

Other funds holding DXCM

Prosperity Financial Group's DXCM Position: Q3 2024 in Review

Prosperity Financial Group sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,912 shares — an estimated $330K sold.

Prosperity Financial Group first reported a position in DXCM in Q4 2022 and held it in 7 quarters. The position peaked at $356K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Prosperity Financial Group reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Prosperity Financial Group sold 2,912 DexCom shares in Q3 2024, an estimated $330K.
  • Prosperity Financial Group first reported a position in DexCom in Q4 2022 and held it in 7 quarters.
  • Prosperity Financial Group's DexCom position peaked at $356K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Prosperity Financial Group's 13F filing for Q3 2024, filed 13 Nov 2024.